# United Therapeutics (stock symbol: UTHR) Logo in transparent PNG and SVG formats

## United Therapeutics Logo large

### United Therapeutics Logo large Download PNG (39.02 KB)

![United Therapeutics Logo large Download PNG (39.02 KB)](/img/orig/UTHR_BIG-98a75930.png)

### United Therapeutics Logo large Download SVG (7.41 KB)

![United Therapeutics Logo large Download SVG (7.41 KB)](/img/orig/UTHR_BIG-b1b46340.svg)

## United Therapeutics Logo icon format

### United Therapeutics Logo icon format Download PNG (20.53 KB)

![United Therapeutics Logo icon format Download PNG (20.53 KB)](/img/orig/UTHR-c3dfc96a.png)

### United Therapeutics Logo icon format Download SVG (2.41 KB)

![United Therapeutics Logo icon format Download SVG (2.41 KB)](/img/orig/UTHR-7284409c.svg)

## United Therapeutics Logo large for dark backgrounds

### United Therapeutics Logo large for dark backgrounds Download PNG (24.5 KB)

![United Therapeutics Logo large for dark backgrounds Download PNG (24.5 KB)](/img/orig/UTHR_BIG.D-8df1d73f.png)

### United Therapeutics Logo large for dark backgrounds Download SVG (7.38 KB)

![United Therapeutics Logo large for dark backgrounds Download SVG (7.38 KB)](/img/orig/UTHR_BIG.D-a065acab.svg)

## United Therapeutics Logo icon format for dark backgrounds

### United Therapeutics Logo icon format for dark backgrounds Download PNG (20.53 KB)

![United Therapeutics Logo icon format for dark backgrounds Download PNG (20.53 KB)](/img/orig/UTHR.D-9768fb46.png)

### United Therapeutics Logo icon format for dark backgrounds Download SVG (2.41 KB)

![United Therapeutics Logo icon format for dark backgrounds Download SVG (2.41 KB)](/img/orig/UTHR.D-d60a8900.svg)

## About United Therapeutics

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin analogue treprostinil to enhance the exercise ability in PAH patients and pulmonary hypertension associated with interstitial lung disease (PH-ILD); Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing Tyvaso DPI, a dry powder inhalation form of Tyvaso; Remunity Pump, a small, lightweight, durable pump and separate controller; RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Tyvaso PERFECT and TETON studies, which are the studies of Tyvaso in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.

1. Website domain: unither.com
2. Employees: 965
3. Marketcap: $10.65 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
